Medication Management of Benign Prostatic Hyperplasia in the Long-Term Care Setting

If you cannot view the webcast, click here to download the free Flash Player.

Jointly sponsored by the American Academy of CME, Inc and Princeton CME

Target Audience

This activity is designed for long-term care medical directors, nursing directors, and consultant pharmacists.

Learning Objectives

After completing this activity, participants should be able to:

Recognize the prevalence and burden of benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS) in long-term care
Describe LUTS associated with BPH and the impact on patient quality of life
Apply methods to identify and assess the severity of BPH in long-term care
Develop medical and surgical approaches for the management of BPH/LUTS
Describe the interaction of α-blockers with phosphodiesterase-5 inhibitors and recommendations for concomitant use
Implement BPH/LUTS management tactics to maximize clinical outcomes and improve patient quality of life

Credit Eligibility

To be eligible for documentation of credit, individuals must listen to the audio/video component and review the slides for the entire educational activity, complete the 10-question post-test with a score of 70% or better, and complete the evaluation form. Participants who successfully complete the post-test and evaluation form online may immediately print their documentation of credit.

Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.

Release Date: September 14, 2007
Expiration Date: September 14, 2008

Estimated time to complete: 1 hour

There is no fee associated with this activity.

Lecture Components

The audio/video presentation, post-test, and evaluation form are available as a click through via the menu at the top of this page.

CME Accreditation

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the American Academy of CME, Inc and Princeton CME. The American Academy of CME, Inc is accredited by the ACCME to provide continuing medical education for physicians.

The American Academy of CME, Inc designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

To contact the American Academy of CME, Inc, please e-mail dbottinick@academycme.org or call 609-921-6622.

This CME activity is recognized by the American Osteopathic Association for a maximum of 1 Category 2 credit.

CNE Accreditation

The American Academy of CME, Inc is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

The American Academy of CME, Inc designates this activity for 1.0 contact hour.

CPE Accreditation

Princeton CME is accredited by the Accreditation Council for Pharmacy Education as a Provider of continuing pharmacy education (ACPE Provider #452) and complies with the Criteria for Quality and Interpretive Guidelines. This activity is approved for 1 hour credit (0.1 CEU) of continuing pharmacy education (ACPE #452-297-07-019-H01).

Any participant wanting to file a grievance with respect to any aspect of a continuing pharmacy education activity sponsored or cosponsored by Princeton CME may contact the Assistant Director of Continuing Education in writing. The Assistant Director of Continuing Education will review the grievance and respond within 30 days of receiving the written statement. If the participant is unsatisfied with the response, an appeal to the Director of Continuing Education may be made for a second level of review.

Grant Support

Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Presenters

Kevin T. McVary, MD
Professor of Urology
Department of Urology
Northwestern University
Feinberg School of Medicine
Chicago, Illinois

David R. P. Guay, PharmD
Professor
Department of Experimental and Clinical Pharmacology
College of Pharmacy
University of Minnesota
Consultant
Division of Geriatrics
HealthPartners, Inc
Minneapolis, Minnesota

Independent Clinical Reviewer
Claus G. Roehrborn, MD
Professor and Chairman
UT Southwestern Medical Center at Dallas
Department of Urology
Dallas, Texas

Financial Disclosure and Conflicts of Interest

According to the disclosure policy of the American Academy of CME, Inc and Princeton CME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of the Academy and Princeton CME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:
Dr. Guay: Scientific advisory board—Abbott, American Pharmaceutical Association, American Society of Consultant Pharmacists, Express Scripts, Johnson & Johnson Companies, Wyeth Pharmaceuticals; Consultant (clinical trial designs)—Abbey-Moore; Speakers Bureau—Boehringer Ingelheim Pharmaceuticals, Inc, Ortho Women’s Health and Urology; intellectual property patents—Dr. Reddy’s Laboratories (Memantine), Sterne, Kessler, Goldstein, & Fox (Ditropan), Goodwin-Proctor (Daptomycin); Medical writing—Hospira
Dr. McVary: Scientific advisory board—Lilly ICOS, Pfizer; Consultant (clinical trial design)—GlaxoSmithKline, Pfizer; Grant support—GlaxoSmithKline (principal investigator; funds paid to Northwestern University); Speakers bureau—GlaxoSmithKline, Lilly ICOS, Pfizer, sanofi-aventis U.S.
Dr. Roehrborn: Scientific and promotional advisory boards, consultant (clinical trial design, and marketing)—Aeterna Zentaris Inc, CALGB, GlaxoSmithKline, Lilly ICOS, NIDDK, Pfizer, sanofi-aventis U.S., Spectrum, SWOG, VA COOP

Planning Committee Debra Bottinick and Natalie Kirkwood, American Academy of CME, Inc; Randy Robbin and John Savage, Princeton CME; Kristin Dickie and Mary Johnson, Princeton Media Associates have disclosed no relevant financial relationships with any commercial interests.

The American Academy of CME, Inc and Princeton CME require faculty to inform participants whenever off-label/unapproved uses of drugs or devices are discussed in their presentation.

The faculty has disclosed that no off-label/unapproved uses of drugs or devices will be discussed.